Bailes JE, Abusuwwa R, Arshad M, Chowdhry SA, Schleicher D, Hempeck N, et al
Every escalation decision is reviewed by an independent Safety Review Committee, which evaluates all available data against predefined stopping rules
Tirzepatide was FDA-approved for T2D in 2022, and showed impressive weight reductions in subsequent obesity trials
Slowly seeing progress but not doing anything extra and still getting results Love how fast it works with no side effects I have never been so happy with a product
The blots were pulsed with Western Lightning TM Plus-ECL (Perkin-Elmer Life Sciences) and the signals were determined by the intensity of chemiluminescence by LAS-3000 imager (Fujifilm, Tokyo, Japan)